Literature DB >> 33359179

Multiorgan emboli due to an intraluminal thrombus from frozen elephant trunk.

Yuki Imamura1, Ryosuke Kowatari2, Kazuyuki Daitoku1, Shintaro Goto3, Ikuo Fukuda1.   

Abstract

The impact of kinking of the nonstented part of a frozen elephant trunk on the development of adverse effects is unclear. We report a case of an infected thrombus within the kinked nonstented portion of the frozen elephant trunk that resulted in multiorgan embolization. A 45-year-old man presented with a 1-month history of high-grade fever and fatigue. He had undergone emergent total arch replacement and frozen elephant trunk implantation for type A acute aortic dissection 7 years previously. Computed tomography showed an intraluminal thrombus within the kinked nonstented portion of the frozen elephant trunk. An autopsy also showed an intraluminal thrombus within the graft and diffuse microembolization in the abdominal organs. Therefore, in this case, kinking of the nonstented part of the frozen elephant trunk had resulted in an infected intraluminal thrombus, which subsequently caused multiorgan embolization.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Frozen elephant trunk; Intraluminal thrombus; Septic emboli; Total arch replacement

Mesh:

Year:  2021        PMID: 33359179     DOI: 10.1016/j.carpath.2020.107316

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  2 in total

Review 1.  Kinking of Frozen Elephant Trunk Hybrid Prostheses: Incidence, Mechanism, and Management.

Authors:  Fatima Kayali; Sara Qutaishat; Matti Jubouri; Rohan Chikhal; Sven Z C P Tan; Mohamad Bashir
Journal:  Front Cardiovasc Med       Date:  2022-04-27

2.  Computational Analysis of the Related Factors of Deep Vein Thrombosis (DVT) Formation in Patients Undergoing Hip Fracture Surgery.

Authors:  Yi Zhou; Huali Chen; Yan Zhang; Chao Yang; Xiaohui Yi; Shanshan Liu; Yao Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-27       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.